Autopsy report · NCT02447926
Procurement of Leukapheresis Products From End Stage Liver Disease (ESLD) Patients for Immunological Studies
Cause of deathOther
“Successful proof of concept study after 1 subject.”
Life of this trial
- Registered 9 months after it had already started.
- Ran for about 2 years before it stopped.
- 1 participant enrolled.
- Results were posted on the registry 3 years 2 months after it ended.
Vital statistics
- Status
- Terminated
- Phase
- Na
- Sponsor
- Northwestern University
- Sponsor type
- University, hospital or other
- Conditions
- End Stage Liver Disease
- Interventions
- Leukapheresis
- Participants
- 1
- Sites
- 1
- Countries
- United States
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.